サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1317787

エピジェネティクス市場：製品、技術、手法、用途、エンドユーザー別-2023～2030年の世界予測

Epigenetics Market by Product, Technique, Methods, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
エピジェネティクス市場：製品、技術、手法、用途、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エピジェネティクスの世界市場は、2023年に22億1,376万米ドル、CAGR18.78％で大きく成長し、2030年には74億1,674万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のエピジェネティクス市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.エピジェネティクスの世界市場規模および予測は？

2.予測期間中、世界のエピジェネティクス市場を形成するCOVID-19の阻害要因と影響は？

3.エピジェネティクスの世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.エピジェネティクスの世界市場における競争戦略は？

5.エピジェネティクスの世界市場における技術動向と規制の枠組みは？

6.エピジェネティクスの世界市場における主要ベンダーの市場シェアは？

7.エピジェネティクスの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で慢性疾患や遺伝性疾患の有病率が大幅に増加
      • 創薬と開発に対する政府の有利な取り組みと投資
      • 医薬品およびバイオ医薬品製造への投資の増加
    • 抑制要因
      • エピジェネティクスの認識不足と適用の制限
    • 機会
      • エピジェネティクスの発展に向けた継続的な研究開発活動
      • 世界中で新たな感染症が出現
    • 課題
      • 研究開発活動のための熟練した専門家の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 エピジェネティクス市場：製品別

  • イントロダクション
  • 酵素
    • DNA修飾酵素
    • タンパク質修飾酵素
  • 装置と付属品
  • 試薬とキット
    • 5-hmCおよび5-mC分析キット
    • 抗体
    • 亜硫酸水素塩変換キット
    • ChiP-seqキット
    • ヒストン
    • 全ゲノム増幅キット
  • サービス
  • ソフトウェア

第7章 エピジェネティクス市場：技術別

  • イントロダクション
  • 定量的ポリメラーゼ連鎖反応
  • 質量分析法
  • 次世代シーケンス
  • ポリメラーゼ連鎖反応
  • 超音波処理

第8章 エピジェネティクス市場：手法別

  • イントロダクション
  • DNAメチル化
  • ヒストン修飾

第9章 エピジェネティクス市場：用途別

  • イントロダクション
  • 心血管疾患
  • 発生生物学
  • 免疫学
  • 代謝性疾患
  • 腫瘍学

第10章 エピジェネティクス市場：エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • 受託研究機関
  • 製薬およびバイオテクノロジー企業

第11章 南北アメリカのエピジェネティクス市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のエピジェネティクス市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのエピジェネティクス市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第15章 掲載企業一覧

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
  • FIGURE 2. EPIGENETICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EPIGENETICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2022 VS 2030 (%)
  • FIGURE 6. EPIGENETICS MARKET SIZE, BY METHODS, 2022 VS 2030 (%)
  • FIGURE 7. EPIGENETICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. EPIGENETICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 9. EPIGENETICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. EPIGENETICS MARKET DYNAMICS
  • FIGURE 11. EPIGENETICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EPIGENETICS MARKET SIZE, BY METHODS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. EPIGENETICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EPIGENETICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 6. EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 11. EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. EPIGENETICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 27. EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 331. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 332. EPIGENETICS MARKET LICENSE & PRICING
目次
Product Code: MRR-0D217D5ADE5E

The Global Epigenetics Market is forecasted to grow significantly, with a projected USD 2,213.76 million in 2023 at a CAGR of 18.78% and expected to reach a staggering USD 7,416.74 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Epigenetics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Epigenetics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Enzymes, Instruments & Accessories, Reagents & Kits, Service, and Software. The Enzymes is further studied across DNA-Modifying Enzymes and Protein-Modifying Enzymes. The Reagents & Kits is further studied across 5-hmC & 5-mC Analysis Kit, Antibodies, Bisulfite Conversion Kits, ChiP-seq Kits, Histones, and Whole Genome Amplification Kits. The Service is projected to witness significant market share during forecast period.

Based on Technique, market is studied across quantitative Polymerase Chain Reaction, Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction, and Sonication. The Polymerase Chain Reaction is projected to witness significant market share during forecast period.

Based on Methods, market is studied across DNA Methylation and Histone Modifications. The Histone Modifications is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiovascular Diseases, Developmental Biology, Immunology, Metabolic Diseases, and Oncology. The Metabolic Diseases is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Epigenetics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Epigenetics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Epigenetics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Epigenetics Market?

4. What is the competitive strategic window for opportunities in the Global Epigenetics Market?

5. What are the technology trends and regulatory frameworks in the Global Epigenetics Market?

6. What is the market share of the leading vendors in the Global Epigenetics Market?

7. What modes and strategic moves are considered suitable for entering the Global Epigenetics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Epigenetics Market, by Product, 2022 vs 2030
  • 4.3. Epigenetics Market, by Technique, 2022 vs 2030
  • 4.4. Epigenetics Market, by Methods, 2022 vs 2030
  • 4.5. Epigenetics Market, by Application, 2022 vs 2030
  • 4.6. Epigenetics Market, by End User, 2022 vs 2030
  • 4.7. Epigenetics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in prevalence of chronic and genetic disorders worldwide
      • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
      • 5.1.1.3. Rising investments in pharmaceuticals and biopharmaceuticals manufacturing
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness and limited application of epigenetics
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for advancement of epigenetics
      • 5.1.3.2. Emergence of novel infectious disorders worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals for research and development activities
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Epigenetics Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymes
    • 6.2.1. DNA-Modifying Enzymes
    • 6.2.2. Protein-Modifying Enzymes
  • 6.3. Instruments & Accessories
  • 6.4. Reagents & Kits
    • 6.4.1. 5-hmC & 5-mC Analysis Kit
    • 6.4.2. Antibodies
    • 6.4.3. Bisulfite Conversion Kits
    • 6.4.4. ChiP-seq Kits
    • 6.4.5. Histones
    • 6.4.6. Whole Genome Amplification Kits
  • 6.5. Service
  • 6.6. Software

7. Epigenetics Market, by Technique

  • 7.1. Introduction
  • 7.2. quantitative Polymerase Chain Reaction
  • 7.3. Mass Spectrometry
  • 7.4. Next-Generation Sequencing
  • 7.5. Polymerase Chain Reaction
  • 7.6. Sonication

8. Epigenetics Market, by Methods

  • 8.1. Introduction
  • 8.2. DNA Methylation
  • 8.3. Histone Modifications

9. Epigenetics Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Developmental Biology
  • 9.4. Immunology
  • 9.5. Metabolic Diseases
  • 9.6. Oncology

10. Epigenetics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Epigenetics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing